简体中文 | 繁體中文 | English

CONVIDIEN

Covidien to Present at Morgan Stanley Conference

2009-09-10 10:54
  • zh_cn
  • zh_hant
  • en

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Morgan Stanley 2009 Global Healthcare Unplugged Conference in New York on Tuesday, September 15, 2009. Chairman, President and Chief Executive Officer Richard J. Meelia will represent the company in a session scheduled at 2:45 p.m. ET. Investors and others who are interested are invited to listen to a live webcast of the presentation on the company's website at: http://investor.covidien.com.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2008 revenue of $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

Contacts

Covidien
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
eric.kraus@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Brian Nameth, 508-452-4363
Director
Investor Relations
brian.nameth@covidien.com